Lex

Unpicking Pfizer’s AstraZeneca bid

British pharmaceutical company AstraZeneca has rejected US drug maker Pfizer’s latest £50 share offer. Lex’s Robert Armstrong and Joseph Cotterill examine the cost and tax savings implied in the bid.